$BG

Bunge Global SA (BG): Results of Operations and Financial Condition

Bunge Global SA (BG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 epr06302026.htm EX-99.1 Document Bunge Reports Second Quarter 2026 Results St. Louis, MO - July 29, 2026 - Bunge Global SA (NYSE: BG) today reported second quarter 2026 results • Q2 GAAP diluted EPS of $3.47 vs. $2.61 in the prior year; $2.00 vs. $1.31 on an adjusted ba

Original reporting
Published Jul 29, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$BG
Bullish
high confidence
Mentioned
$BG
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BGBullishMed
01

Why it matters

Traders can update models using the raised adjusted EPS range ($9.25 to $9.75) and reassess segment momentum (Soybean Processing and Refining, Softseed Processing and Refining) plus capital return via the ~$250M share repurchase completion.

02

Market read

Fresh earnings and guidance details are likely to drive revisions to FY estimates and near-term positioning in BG.

03

What to watch

Foreign exchange impacts and commodity/freight-driven mark-to-market effects are material in the reconciliation, which can reverse in subsequent quarters.

Relevance 7/10Novelty 8/10Timing: after-hours filing of Q2 results and raised full-year adjusted EPS outlook

Background

This is an SEC Form 8-K (Item 2.02) with Bunge’s Q2 2026 results and an updated full-year adjusted EPS outlook.

Company-level read

Ticker impact

$BGBullishHigh confidence
Context

Bunge reported Q2 2026 GAAP diluted EPS of $3.47 and raised full-year adjusted EPS outlook to $9.25 to $9.75.

Expected impact

Near-term bias to the upside as traders reprice earnings power and capital return expectations based on the raised outlook.

Evidence & confidence

The 8-K includes specific EPS results, segment EBIT drivers, and a concrete guidance range increase, which are direct inputs to valuation and positioning.

Market effects

Improving performance in soybean and softseed processing/refining segments may support sentiment for ag-processing margins and crush/refining read-throughs.

Management cites stronger North and South American value chains, with Argentina and Brazil capacity/processing improvements as key drivers.

The company highlights shifting trade flows and geopolitical uncertainty, implying demand and logistics conditions remain a key swing factor for global ag supply chains.

Counterpoint

Adjusted results exclude mark-to-market timing differences and certain gains/charges, so the headline strength may overstate underlying cash earnings power.

Key entities

  • Bunge Global SA

    Reported Q2 2026 results, highlighted segment drivers, completed ~$250M of share repurchases, and raised full-year adjusted EPS outlook.

Related articles

$BGMed

Why is Bunge stock rallying today?

Investing.com reports Bunge shares rose about 3.7% after its Q2 2026 results (released July 29). Adjusted EPS was $2.00 vs ~$1.95 expected, and revenue was $24.04B vs expectations. The stock had fallen on concerns about Viterra integration and working capital. Analysts at Texas Capital and BMO reiterated Buy, with a $150 target, and an Aug. 18 ex-dividend date for a $0.72 quarterly payment.

$BGMedAI 8/10

PTSB acquisition: Shareholders approve transaction

Permanent TSB (PTSB) shareholders approved BAWAG Group’s all-cash offer to buy 100% of PTSB’s issued share capital. The scheme meeting vote backed the transaction with 91% of votes cast, and related resolutions at the EGM received required approvals. Completion is expected in Q4 2026 or Q1 2027, pending court sanction and remaining regulatory approvals.

$BGMedAI 8/10

Bunge Global Raises 2026 Adj. EPS Outlook Range

Bunge Global SA (BG) raised its 2026 adjusted EPS outlook to $9.25 to $9.75 from $9.00 to $9.50, citing higher Soybean Processing and Refining and Softseed Processing and Refining, and lower Grain Merchandising and Milling. Q2 earnings were $678 million, or $3.47/share, versus $354 million, or $2.61/share a year earlier. Revenue rose 88.3% to $24.041 billion. Shares were up 1.29% pre-market at $118.88.

$BGMed

Bunge Global (NYSE:BG) Beats Q2 CY2026 Sales Expectations

Bunge Global (NYSE:BG) reported Q2 CY2026 results, with sales rising 88.3% year on year to $24.04 billion, topping Wall Street’s revenue estimate by 9.3%, according to the company. Non-GAAP profit was $2 per share, 2.9% above consensus. The article also cites Q2 cash burn of $1.03 billion and notes the stock was about $117.50 after results.

$BGMedAI 8/10

Bunge beats second-quarter profit estimates on strong processing margins By Reuters

Reuters reports Bunge beat Wall Street’s Q2 profit estimates, citing strong soybean and softseed processing margins. The company raised its 2026 adjusted earnings forecast to $9.25 to $9.75 per share. Soybean processing and refining net sales were $12.07 billion, and softseed net sales were $4.09 billion. Reuters links improved demand to higher U.S. corn and soybean prices.

$RIVNMed

What Rivian And Lucid's Latest Earnings Say About The EV Startup Race

The article compares Rivian and Lucid after their 2021 IPOs, focusing on recent earnings. Lucid reported $405 million revenue in the quarter, with net loss widening to over $1 billion, and announced an “operational reset” tied to $1.4 billion cash savings in 2026, plus $3 billion liquidity. Rivian reported $1.66 billion revenue last quarter and raised 2026 delivery guidance to 65,000-70,000 vehicles.